BFM
BJDX icon

Boothbay Fund Management’s Bluejay Diagnostics BJDX Stock Holding History

Boothbay Fund Management’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6K Buy
+27,130
New +$70.2K ﹤0.01% 2130

Other funds holding BJDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Boothbay Fund Management's BJDX Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Bluejay Diagnostics (BJDX) in Q2 2026: 27,130 shares worth $32.6K. The stake represents ﹤0.01% of the portfolio and ranks #2130 among its holdings.

8 funds tracked by Wall St. Rank hold BJDX as of Q2 2026.

  • Boothbay Fund Management held 27,130 shares of Bluejay Diagnostics worth $32.6K as of Q2 2026.
  • Bluejay Diagnostics was a new Boothbay Fund Management position in Q2 2026.
  • Bluejay Diagnostics made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2130 holding.
  • 8 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.